TMA Can Be Overlooked in Some Stem Cell Patients, Requires Specific Treatment As many as 30 percent of children and young adults receiving hematopoietic stem cell transplants develop thrombotic microangioplasty (TMA) in the weeks following transplant. However, the condition can be overlooked and go untreated because it frequently occurs alongside graft-versus-host disease (GVHD), according to blood disease experts at Cincinnati Children’s.
Read Featured ResearchResearch and Training Details | |
---|---|
Faculty | 14 |
Joint Appointment Faculty | 4 |
Research Fellows and Post Docs | 1 |
Research Graduate Students | 1 |
Total Annual Grant Award Dollars | $502,686 |
Total Annual Industry Award Dollars | $644,630 |
Clinical Activities and Training | |
---|---|
Staff Physicians | 7 |
Clinical Fellows | 5 |
Inpatient Encounters | 462 |
Outpatient Encounters | 5,895 |